Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulants.
Andreas CapiauEls MehuysInge Van TongelenThierry ChristiaensAn De SutterStephane SteurbautSouad MoudallelSilas RydantBernard VrijensTine L M De BackerKoen BousseryPublished in: Heart (British Cardiac Society) (2020)
Our data indicate that long-term NOAC users have high implementation adherence and a positive attitude towards NOAC therapy. However, taking into account patients' thromboembolic risk and NOACs' short half-lives, further optimisation of NOAC use seems warranted in this population.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- primary care
- chronic kidney disease
- mental health
- prognostic factors
- type diabetes
- peritoneal dialysis
- stem cells
- electronic health record
- quality improvement
- machine learning
- weight loss
- glycemic control
- bone marrow
- mesenchymal stem cells
- cell therapy
- data analysis
- smoking cessation